Annual report pursuant to Section 13 and 15(d)

Statements of Operations

v3.21.1
Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Operating Expenses:    
Research and development $ 5,853,291 $ 3,965,543
General and administrative 5,074,694 4,279,357
Total Operating Expenses 10,927,985 8,244,900
Loss From Operations (10,927,985) (8,244,900)
Other Income (Expense)    
Interest income 32,495 95,234
Other income 2,500
Warrant modification expense (441,763)
Total other income (expense) 34,995 (346,529)
Loss Before Provision For Income Taxes (10,892,990) (8,591,429)
Benefit from income taxes
Net Loss $ (10,892,990) $ (8,591,429)
Net loss per share, basic and diluted $ (0.87) $ (0.87)
Weighted average shares, basic and diluted 12,463,127 9,852,486